INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol WALPAR
MSEI Symbol NOTLISTED
ISIN INE0G2G01015
Name of Company Walpar Nutritions Limited
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 15-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 12-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Manufacturing of Pharmaceutical, nNutraceutical, Herbal and Ayurvedic Products
Start date and time of board meeting 15-May-2025   10:30:00
End date and time of board meeting 15-May-2025   16:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-07-05
Indicate Company website link for updated RPT policy of the Company https://www.walparnutritions.com/assets/pdf/related-party-policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no default on Loans and Debt Securities and therefor disclosure on it is not applicable


Financial Results — Other than Bank
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 352462000 601616000
Other income 660000 1003000
Total Income 353122000 602619000
2 Expenses
(a) Cost of materials consumed 307992000 527530000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 8021000 2925000
(d) Employee benefit expense 9547000 18994000
(e) Finance costs 506000 1013000
(f) Depreciation and amortisation expense 2346000 4104000
(g) Other Expenses
1 Other Expenses 14175000 23729000
Total other expenses 14175000 23729000
Total expenses 342587000 578295000
3 Profit before exceptional and extraordinary items and tax 10535000 24324000
4 Exceptional items 0 0
5 Profit before extraordinary items and tax 10535000 24324000
6 Extraordinary items 0 0
7 Profit before tax 10535000 24324000
8 Tax Expense
Current tax 2693000 6053000
Deferred tax 2073000 1344000
Total tax expenses 4766000 7397000
9 Net Profit Loss for the period from continuing operations 5769000 16927000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 5769000 16927000
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 5769000 16927000
17 Details of equity share capital
Paid-up equity share capital 93904000 93904000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 0
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.61 1.8
Diluted earnings (loss) per share from continuing and discontinued operations 0.61 1.8
20 Debt equity ratio 0.0 0.0
21 Debt service coverage ratio 0.0025 0.0025
22 Interest service coverage ratio 4.0E-4 3.0E-4
23 Disclosure of notes on financial results


Remarks
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 24324000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 1013000
Adjustments for depreciation and amortisation expense 4104000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 5117000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories 2553000
Adjustments for decrease (increase) in trade receivables -68560000
Adjustments for decrease (increase) in other current assets -830000
Adjustments for increase (decrease) in trade payables 51933000
Adjustments for increase (decrease) in other current liabilities 5767000
Adjustments for provisions 10104000
Total adjustments for working capital 967000
Total adjustments for reconcile profit (loss) 6084000
Net cash flows from (used in) operations 30408000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 3327000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items 27081000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities 27081000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 12306000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items -12306000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities -12306000
Cash flows from used in financing activities
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -3153000
Repayments of borrowings 0
Dividends paid 0
Interest paid 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash -1013000
Net cash flows from (used in) financing activities before extraordinary items -4166000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities -4166000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 10609000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 10609000
Cash and cash equivalents cash flow statement at beginning of period 4466000
Cash and cash equivalents cash flow statement at end of period 15075000


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital 93904000
Reserves and surplus 56256000
Money received against share warrants 0
Total shareholders' funds 150160000
2 Share application money pending allotment 0
3 Deferred government grants 0
4 Minority interest
5 Non-current liabilities
Long-term borrowings 0
Deferred tax liabilities (net) 182000
Foreign currency monetary item translation difference liability account 0
Other long-term liabilities 0
Long-term provisions 0
Total non-current liabilities 182000
6 Current liabilities
Short-term borrowings 0
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 136330000
Total Trade payable 136330000
Other current liabilities 16553000
Short-term provisions 5995000
Total current liabilities 158878000
Total equity and liabilities 309220000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 22323000
Producing properties 0
Intangible assets 576000
Preproducing properties 0
Property, Plant and Equipment capital work-in-progress 0
Intangible assets under development or work-in-progress 330000
Total Property, Plant and Equipment and Intangible assets 23229000
ii Non-current investments 46984000
v Deferred tax assets (net) 0
vi Foreign currency monetary item translation difference asset account 0
vii Long-term loans and advances 0
viii Other non-current assets 442000
Total non-current assets 70655000
Current assets
Current investments 0
Inventories 47740000
Trade receivables 169471000
Cash and cash equivalents 15072000
Bank balance other than cash and cash equivalents 0
Short-term loans and advances 2957000
Other current assets 3325000
Total current assets 238565000
Total assets 309220000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 A Y & Company Yes 31-Jul-2027


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth


Signatories details

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date


Signatory Details
Name of signatory
Designation of person
Place
Date


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Walpar Nutritions Limited Kalpesh P Ladhawala Director Remuneration 600000 NA 600000 0 0
2 Walpar Nutritions Limited Sejal K Ladhawala Director Remuneration 600000 NA 600000 0 0
3 Walpar Nutritions Limited Tanmaybhai Shah Director Remuneration 600000 NA 600000 0 0
4 Walpar Nutritions Limited Abhishek Patel Director Remuneration 600000 NA 600000 0 0
5 Walpar Nutritions Limited Fenil P Shah Director Remuneration 420000 NA 420000 0 0
6 Walpar Nutritions Limited Jignesh Modi Director Remuneration 600000 NA 600000 0 0
7 Walpar Nutritions Limited Krunal J Patel Director Remuneration 420000 NA 420000 0 0
8 Walpar Nutritions Limited Nidhi Tanmay Shah Director Remuneration 600000 NA 600000 0 0
9 Walpar Nutritions Limited Priyanka Sanjay Shah Company Secretary Remuneration 13000 NA 13000 0 0
10 Walpar Nutritions Limited Priyanka Joshi Company Secretary Remuneration 45000 NA 45000 0 0
11 Walpar Nutritions Limited Walpar Wellness Private Limited Subsidiary Company Purchase of goods or services 51503000 NA 51503000 0 0
12 Walpar Nutritions Limited Walpar Nutri Science Private Limited Subsidiary Company Purchase of goods or services 3899000 NA 3899000 0 0
13 Walpar Nutritions Limited Walpar Wellness Private Limited Subsidiary Company Sale of goods or services 62756000 NA 62756000 0 0
14 Walpar Nutritions Limited Walpar Nutri Science Private Limited Subsidiary Company Sale of goods or services 3986000 NA 3986000 0 0
15 Walpar Nutritions Limited Walpar Nutri Science Private Limited Subsidiary Company Loan 1600000 NA 1600000 0 0
16 Walpar Nutritions Limited Walpar Wellness Private Limited Subsidiary Company Loan 2005000 NA 2005000 0 0
17 Walpar Nutritions Limited Sejal K Ladhawala Director Loan 2000000 NA 2000000 0 0
18 Walpar Nutritions Limited Rahiben A Thakkar Company Secretary Remuneration 28000 NA 28000 0 0
Total value of transaction during the reporting period 132275000





Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt